AOCI represents cumulative gains and losses that are not reflected in earnings. AOCI balances and the components of other comprehensive income (loss) are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balance at December 31, 2024 | $ | (14,848) | | | Available for sale securities: | | Net unrealized gain (loss), net of tax expense (benefit) of $253 | 808 | | | | Other reclassifications included in other revenue, net of tax expense (benefit) of $2 | 8 | | | Held to maturity securities: | | | | Amortization of amounts previously recorded upon transfer from available for sale, net of tax expense (benefit) of $128 | 410 | | | | | | | | Other (1) | 1 | | | Balance at March 31, 2025 | $ | (13,621) | | | | | Balance at December 31, 2025 | $ | (10,983) | | | Available for sale securities: | | Net unrealized gain (loss), net of tax expense (benefit) of $2 | 6 | | | | | | | Held to maturity securities: | | | | Amortization of amounts previously recorded upon transfer from available for sale, net of tax expense (benefit) of $117 | 379 | | | Derivatives designated as cash flow hedging instruments: | | Net unrealized gain (loss), net of tax expense (benefit) of $(54) | (171) | | Reclassifications included in interest revenue, net of tax expense (benefit) of $4 | 14 | | Other (1) | (2) | | | Balance at March 31, 2026 | $ | (10,757) | |
(1) Tax expense (benefit) was less than $500 thousand.
|